Cargando…

Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction

BACKGROUND: Free fatty acids (FFA), oxidized low-density lipoprotein (LDL) and its antibodies, lipid profile markers, which are formed under oxidative stress, play an important role in atherosclerotic disease. Assess the levels of these markers in myocardial infarction patients depending on the exte...

Descripción completa

Detalles Bibliográficos
Autores principales: Gruzdeva, Olga, Uchasova, Evgenya, Dyleva, Yulia, Belik, Ekaterina, Karetnikova, Victoria, Shilov, Alexander, Barbarash, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098672/
https://www.ncbi.nlm.nih.gov/pubmed/25008008
http://dx.doi.org/10.1186/1476-511X-13-111
_version_ 1782326383170551808
author Gruzdeva, Olga
Uchasova, Evgenya
Dyleva, Yulia
Belik, Ekaterina
Karetnikova, Victoria
Shilov, Alexander
Barbarash, Olga
author_facet Gruzdeva, Olga
Uchasova, Evgenya
Dyleva, Yulia
Belik, Ekaterina
Karetnikova, Victoria
Shilov, Alexander
Barbarash, Olga
author_sort Gruzdeva, Olga
collection PubMed
description BACKGROUND: Free fatty acids (FFA), oxidized low-density lipoprotein (LDL) and its antibodies, lipid profile markers, which are formed under oxidative stress, play an important role in atherosclerotic disease. Assess the levels of these markers in myocardial infarction patients depending on the extent of coronary artery disease (CAD). METHODS: ST-elevation MI patients with hemodynamically significant stenoses of ≥75% in one, two, three, or more coronary arteries were examined. The patients were divided into three groups according to the severity of coronary lesions. Patients had a ≥75% stenotic lesion in one coronary artery (group 1, n = 135), two coronary arteries (group 2, n = 115), or three or more coronary arteries (group 3, n = 150). The control group comprised healthy subjects (n = 33). RESULTS: FFA levels on day 1 from MI onset were higher in groups 1, 2, and 3 compared with controls. On day 1 from MI onset, oxidized LDL levels were significantly higher in groups 2 and 3 than those in controls (both р = 0.001). Oxidized LDL levels were significantly higher in patients with multivessel CAD compared with those with single-vessel CAD on days 1 and 12. Antibody levels increased with the number of affected arteries. CONCLUSION: High levels FFA, oxidized LDL and its antibody, lipid profile markers, and parameters of the pro/antioxidant systems persist during the subacute phase of MI.
format Online
Article
Text
id pubmed-4098672
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40986722014-07-16 Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction Gruzdeva, Olga Uchasova, Evgenya Dyleva, Yulia Belik, Ekaterina Karetnikova, Victoria Shilov, Alexander Barbarash, Olga Lipids Health Dis Research BACKGROUND: Free fatty acids (FFA), oxidized low-density lipoprotein (LDL) and its antibodies, lipid profile markers, which are formed under oxidative stress, play an important role in atherosclerotic disease. Assess the levels of these markers in myocardial infarction patients depending on the extent of coronary artery disease (CAD). METHODS: ST-elevation MI patients with hemodynamically significant stenoses of ≥75% in one, two, three, or more coronary arteries were examined. The patients were divided into three groups according to the severity of coronary lesions. Patients had a ≥75% stenotic lesion in one coronary artery (group 1, n = 135), two coronary arteries (group 2, n = 115), or three or more coronary arteries (group 3, n = 150). The control group comprised healthy subjects (n = 33). RESULTS: FFA levels on day 1 from MI onset were higher in groups 1, 2, and 3 compared with controls. On day 1 from MI onset, oxidized LDL levels were significantly higher in groups 2 and 3 than those in controls (both р = 0.001). Oxidized LDL levels were significantly higher in patients with multivessel CAD compared with those with single-vessel CAD on days 1 and 12. Antibody levels increased with the number of affected arteries. CONCLUSION: High levels FFA, oxidized LDL and its antibody, lipid profile markers, and parameters of the pro/antioxidant systems persist during the subacute phase of MI. BioMed Central 2014-07-09 /pmc/articles/PMC4098672/ /pubmed/25008008 http://dx.doi.org/10.1186/1476-511X-13-111 Text en Copyright © 2014 Gruzdeva et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Gruzdeva, Olga
Uchasova, Evgenya
Dyleva, Yulia
Belik, Ekaterina
Karetnikova, Victoria
Shilov, Alexander
Barbarash, Olga
Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction
title Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction
title_full Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction
title_fullStr Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction
title_full_unstemmed Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction
title_short Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction
title_sort multivessel coronary artery disease, free fatty acids, oxidized ldl and its antibody in myocardial infarction
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098672/
https://www.ncbi.nlm.nih.gov/pubmed/25008008
http://dx.doi.org/10.1186/1476-511X-13-111
work_keys_str_mv AT gruzdevaolga multivesselcoronaryarterydiseasefreefattyacidsoxidizedldlanditsantibodyinmyocardialinfarction
AT uchasovaevgenya multivesselcoronaryarterydiseasefreefattyacidsoxidizedldlanditsantibodyinmyocardialinfarction
AT dylevayulia multivesselcoronaryarterydiseasefreefattyacidsoxidizedldlanditsantibodyinmyocardialinfarction
AT belikekaterina multivesselcoronaryarterydiseasefreefattyacidsoxidizedldlanditsantibodyinmyocardialinfarction
AT karetnikovavictoria multivesselcoronaryarterydiseasefreefattyacidsoxidizedldlanditsantibodyinmyocardialinfarction
AT shilovalexander multivesselcoronaryarterydiseasefreefattyacidsoxidizedldlanditsantibodyinmyocardialinfarction
AT barbarasholga multivesselcoronaryarterydiseasefreefattyacidsoxidizedldlanditsantibodyinmyocardialinfarction